Boston Scientific Initiates Another ICD Battery Depletion Recall
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is warning customers that batteries in 73,000 of its implantable cardioverter defibrillators could run out faster than indicated on their label
You may also be interested in...
CMS Reconsiders Role In Covering Recall-Related Patient Monitoring Costs
CMS is weighing options to shift more of the cost of medical check-ups that result from product recalls from Medicare to manufacturers
CMS Reconsiders Role In Covering Recall-Related Patient Monitoring Costs
CMS is weighing options to shift more of the cost of medical check-ups that result from product recalls from Medicare to manufacturers
Boston Scientific Forgoes Cost Cuts, Predicting Stent/ICD Market Recovery
Boston Scientific will maintain current cost structures in its drug-eluting stent and cardiac rhythm management businesses in the near term, anticipating both markets will soon recover from a 2006 slump